Malignant melanoma and Body height decreased

Summary:

Body height decreased is reported only by a few people with Malignant melanoma.

The study analyzes which people have Body height decreased with Malignant melanoma. It is created by eHealthMe based on 3 people who have Body height decreased and Malignant melanoma from the Food and Drug Administration (FDA), and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Aug, 05, 2022

3 people who have Malignant Melanoma and Body Height Decreased are studied.


What is Malignant melanoma?

Malignant melanoma (skin cancer rises from melancytes) is found to be associated with 1,123 drugs and 687 conditions by eHealthMe.

What is Body height decreased?

Body height decreased is found to be associated with 1,143 drugs and 895 conditions by eHealthMe.

Number of Body height decreased in Malignant melanoma reports submitted per year:

Would you have Body height decreased when you have Malignant melanoma?

Gender of people who have Malignant Melanoma and experienced Body Height Decreased *:

  • female: 33.33 %
  • male: 66.67 %

Age of people who have Malignant Melanoma and experienced Body Height Decreased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 33.33 %
  • 60+: 66.67 %

Common co-existing conditions for these people *:

  1. Osteoporosis (bones weak and more likely to break): 2 people, 66.67%
  2. Sinus Disorder (disease of sinus): 1 person, 33.33%
  3. Respiratory Disorder (respiratory disease): 1 person, 33.33%
  4. Migraine (headache): 1 person, 33.33%
  5. Irritable Bowel Syndrome: 1 person, 33.33%
  6. Incontinence (lack of moderation or self-control): 1 person, 33.33%
  7. High Blood Cholesterol: 1 person, 33.33%
  8. Headache (pain in head): 1 person, 33.33%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 33.33%
  10. Dizziness: 1 person, 33.33%

Common drugs taken by these people *:

  1. Zelboraf: 2 people, 66.67%
  2. Vitamin D: 2 people, 66.67%
  3. Synthroid: 1 person, 33.33%
  4. Spiriva: 1 person, 33.33%
  5. Percocet: 1 person, 33.33%
  6. Oxybutynin: 1 person, 33.33%
  7. Nexium: 1 person, 33.33%
  8. Meclizine: 1 person, 33.33%
  9. Fosamax: 1 person, 33.33%
  10. Flonase: 1 person, 33.33%

Common symptoms for these people *:

  1. Breast Calcifications (deposits of calcium that can be seen on a mammogram of the breast): 2 people, 66.67%
  2. Femur Fracture: 2 people, 66.67%
  3. Asthma: 2 people, 66.67%
  4. Constipation: 2 people, 66.67%
  5. Chest Pain: 2 people, 66.67%
  6. Joint Pain: 2 people, 66.67%
  7. Breathing Difficulty: 2 people, 66.67%
  8. Drug Ineffective: 1 person, 33.33%
  9. Drug Intolerance (drug sensitivity): 1 person, 33.33%
  10. Dry Mouth: 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Body height decreased?

Check whether Body height decreased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Body height decreased:

Common drugs associated with Body height decreased:

All the drugs that are associated with Body height decreased:

Common conditions associated with Body height decreased:

All the conditions that are associated with Body height decreased:

How the study uses the data?

The study is based on Body height decreased and Malignant melanoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: